Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00149799. We help you review the study, but cannot decide medical eligibility.
CompletedNCT00149799
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
This study is completed. It focuses on somatic symptom disorders and currently lists study information in the United States.
Somatic symptom disorders, Body dysmorphic disorder, ...DrugOver 18 Years
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Boston, United States · Providence, United StatesSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00149799
- Official title
- Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder
Recruitment & locations
CompletedBoston · Providence
Registry details
Registry conditions (original wording)
Anxiety Disorders; Somatoform Disorders
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Escitalopram and Placebo.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as completed.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT05729373
A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder
This study is completed in the United States, in Bulgaria, in Estonia, .... It focuses on anxiety.
CompletedNCT05407064
A Dose-Finding Study of MM120 (LSD D-Tartrate) for Anxiety Symptoms
This study is completed. It focuses on anxiety and currently lists study information in the United States.
CompletedNCT05193409
BNC210 for anxiety
This study is completed in the United States. It is testing BNC210 for anxiety.